Dr. Shadab Anjum
Profile
Dr. Shadab Anjum is a skilled genomics researcher, predominantly concentrating on uterine fibroid disease during his Ph.D period. His expertise involves using innovative techniques for thorough investigation into the genetic complexities of this illness. Furthermore, Dr. Shadab made contributions to the research on Chikungunya and Dengue.
Dr. Shadab skillfully applied a wide range of techniques during his Ph.D. research, including PCR, Elisa, Gel-electrophoresis (1d-GE/2d-GE), RT-qPCR, and Next-generation sequencing. His academic endeavors have yielded multiple paper publications, demonstrating his noteworthy contributions to the scientific world. In addition, Dr. Shadab presents his research findings at numerous national and international conferences, actively promoting his discoveries.
Dr. Shadab Anjum gained invaluable experience in sequencing technologies while working at G42-Healthcare in the United Arab Emirates. He focused on clinical samples in particular and made a significant contribution to the Emirati Genome Project.
Currently, Dr. Shadab is connected to the Hortman Stem Cell Laboratory, where he actively participates in studies focused on mesenchymal stem cells, cord tissues, and induced pluripotent stem cells (iPSCs). His research interests are motivated by his enthusiasm with the extraordinary potential of stem cells to transform approaches to treating disease.
